Plasma, aortic, and macrophage 2-AG levels are increased in ApoE/MGL-DKO mice.
Desensitization of CB1R but not CB2R occurs in DKO mice.
DKO mice develop less vulnerable atherosclerotic lesions.
CB2R antagonist treatment reverses plaque phenotype in DKO mice.